Vitamin D and axonal injury in multiple sclerosis
- 13 October 2015
- journal article
- research article
- Published by SAGE Publications in Multiple Sclerosis Journal
- Vol. 22 (8) , 1027-1031
Abstract
Previous studies in patients with multiple sclerosis (MS) have shown an association between high serum 25-hydroxyvitamin D (25[OH]D) levels and decreased inflammatory activity. The purpose of this study was to examine the association between 25(OH)D levels and axonal injury in MS. Cerebrospinal fluid neurofilament light (CSF-NFL) was used as a marker for axonal injury. Patients were identified through clinical practice at the Department of Neurology in Umeå University Hospital, Sweden. Blood draw, magnetic resonance imaging, scoring of disability and lumbar puncture were performed at inclusion in 153 patients, and also at median 12 months follow-up in 87 patients. For analyses of serum 25(OH)D levels and CSF-NFL, enzyme-linked immunosorbent assays were used. There was an inverse association between serum 25(OH)D and CSF-NFL levels in categorical (dichotomized at 75 or 100 nmol/l) analyses. A dose-response effect for 25(OH)D levels on CSF-NFL levels (p for trend=0.034) was also present. Serum 25(OH)D levels above 100 nmol/l were associated with lower CSF-NFL levels independently of ongoing MS treatment. High 25(OH)D levels are associated with decreased axonal injury in MS.Keywords
This publication has 17 references indexed in Scilit:
- Vitamin D as an Early Predictor of Multiple Sclerosis Activity and ProgressionJAMA Neurology, 2014
- Vitamin D and multiple sclerosis: where do we go from here?Expert Review of Neurotherapeutics, 2013
- Immunosuppressive therapy reduces axonal damage in progressive multiple sclerosisMultiple Sclerosis Journal, 2013
- A comparative study of CSF neurofilament light and heavy chain protein in MSMultiple Sclerosis Journal, 2013
- Vitamin D as a protective factor in multiple sclerosisNeurology, 2012
- The initiation and prevention of multiple sclerosisNature Reviews Neurology, 2012
- Sun exposure and vitamin D are independent risk factors for CNS demyelinationNeurology, 2011
- Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumabAnnals of Neurology, 2010
- Neurofilament light as a prognostic marker in multiple sclerosisMultiple Sclerosis Journal, 2010
- Serum 25-Hydroxyvitamin D Levels and Risk of Multiple SclerosisJAMA, 2006